Additionally, amino acid substitutions based on IDH2 gene mutations, leading to mutant IDH2 enzymes, causes the conversion of the normal product α-ketoglutarate to 2-hydroxyglutarate (2HG), which has been shown to act as an oncometabolite and which has been suggested to be responsible for driving tumor progression [31,32]. Here, IDH2 is linked to neoplasm.